Similar articles

• Self-recognition and tumor response to immunotherapy.

  Ernstoff MS. Ernstoff MS. J Clin Oncol. 2005 Sep 1;23(25):5875-7. doi: 10.1200/JCO.2005.95.029. Epub 2005 Aug 8. J Clin Oncol. 2005. PMID: 16087939 No abstract available.
• Immunotherapy of melanoma.

  Parmiani G, Castelli C, Rivoltini L, Casati C, Tully GA, Novellino L, Patuzzo A, Tosi D, Anichini A, Santinami M. Parmiani G, et al. Semin Cancer Biol. 2003 Dec;13(6):391-400. doi: 10.1016/j.semcancer.2003.09.001. Semin Cancer Biol. 2003. PMID: 15001157 Review.
• [Advances in cellular immunotherapy for malignant melanoma].

  López M, Escobar A, Alfaro J, Fodor M, Larrondo M, Ferrada C, Salazar-Onfray F. López M, et al. Rev Med Chil. 2004 Sep;132(9):1115-26. Rev Med Chil. 2004. PMID: 15543770 Review. Spanish.
• The unfulfilled promise of melanoma vaccines.

  Livingston P. Livingston P. Clin Cancer Res. 2001 Jul;7(7):1837-8. Clin Cancer Res. 2001. PMID: 11448892 No abstract available.
• Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.

  Speiser DE, Pittet MJ, Rimoldi D, Guillaume P, Luescher IF, Liénard D, Lejeune F, Cerottini JC, Romero P. Speiser DE, et al. Semin Cancer Biol. 2003 Dec;13(6):461-72. doi: 10.1016/j.semcancer.2003.09.010. Semin Cancer Biol. 2003. PMID: 15001165 Review.